AstraZeneca (Nasdaq:AZN) holds quite a distinction on Novus's newly updated EU Short Disclosure dashboard: It features the most covered shorts over the past month. That in itself isn't newsworthy; it's the order of magnitude between AstraZeneca and its runner-up that bears mention.
The British pharma company saw a 639.58 bp upside on its way from 6.64% short interest to 0.24%. The silver medalist (sorry -- Olympics are on in the background) is French-Italian chipmaker STMicroelectronics (NYSE:STM), which had an otherwise enviable month as its short interest dipped from 2.41% to 1.81%, accompanying a 59.99 bp bump.
Spain's Red Electrica (OTC:RDEIY) utility also ascended the podium.